Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Barrett-Lee

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Expert Opinion on Therapeutic Targets|March 11, 2011
Therapeutic targeting of tumor-stroma interactionsStephen Hiscox, Peter Barrett-Lee, Robert I Nicholson
Maturitas|July 7, 2009
Aromatase inhibitors in breast cancerStephen Hiscox, Eleri Lloyd Davies, Peter Barrett-Lee
Oncotarget|January 21, 2021
PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancerMichael Rees, Chris Smith, Peter Barrett-Lee, et al.
BMC Cancer|June 3, 2016
3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic responseSharath Gangadhara, Chris Smith, Peter Barrett-Lee, et al.
Cancer Treatment Reviews|July 28, 2009
Contemporary issues and the potential uses of capecitabine in metastatic breast cancerPeter Barrett-Lee, François-Clément Bidard, Jean-Yves Pierga
Advances in Radiation Oncology|October 30, 2018
Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapyNicholas Courtier, Tina Gambling, Peter Barrett-Lee, et al.
Future Oncology (London, England)|November 15, 2012
Pro-metastatic tumor-stroma interactions in breast cancerSharath Gangadhara, Peter Barrett-Lee, Robert I Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
Combining Src inhibitors and aromatase inhibitors: a novel strategy for overcoming endocrine resistance and bone lossStephen Hiscox, Peter Barrett-Lee, Annabel C Borley, et al.
Journal of Biomedical Informatics|December 28, 2020
Modified Needleman-Wunsch algorithm for clinical pathway clusteringEmma Aspland, Paul R Harper, Daniel Gartner, et al.
Cancer Treatment Reviews|October 5, 2010
Src-mediated regulation of homotypic cell adhesion: implications for cancer progression and opportunities for therapeutic interventionAnshu Wadhawan, Chris Smith, Robert I Nicholson, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Expert Opinion on Therapeutic Targets|March 11, 2011
Therapeutic targeting of tumor-stroma interactionsStephen Hiscox, Peter Barrett-Lee, Robert I Nicholson
Maturitas|July 7, 2009
Aromatase inhibitors in breast cancerStephen Hiscox, Eleri Lloyd Davies, Peter Barrett-Lee
Oncotarget|January 21, 2021
PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancerMichael Rees, Chris Smith, Peter Barrett-Lee, et al.
BMC Cancer|June 3, 2016
3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic responseSharath Gangadhara, Chris Smith, Peter Barrett-Lee, et al.
Cancer Treatment Reviews|July 28, 2009
Contemporary issues and the potential uses of capecitabine in metastatic breast cancerPeter Barrett-Lee, François-Clément Bidard, Jean-Yves Pierga
Advances in Radiation Oncology|October 30, 2018
Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapyNicholas Courtier, Tina Gambling, Peter Barrett-Lee, et al.
Future Oncology (London, England)|November 15, 2012
Pro-metastatic tumor-stroma interactions in breast cancerSharath Gangadhara, Peter Barrett-Lee, Robert I Nicholson, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2010
Combining Src inhibitors and aromatase inhibitors: a novel strategy for overcoming endocrine resistance and bone lossStephen Hiscox, Peter Barrett-Lee, Annabel C Borley, et al.
Journal of Biomedical Informatics|December 28, 2020
Modified Needleman-Wunsch algorithm for clinical pathway clusteringEmma Aspland, Paul R Harper, Daniel Gartner, et al.
Cancer Treatment Reviews|October 5, 2010
Src-mediated regulation of homotypic cell adhesion: implications for cancer progression and opportunities for therapeutic interventionAnshu Wadhawan, Chris Smith, Robert I Nicholson, et al.
Pageof 4